It was reported yesterday that GreenLight Biosciences Inc, a bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, has named Susan Keefe as its new chief financial officer.
The new chief financial officer is to lead the company's financial strategy and facilitate its growth plan, and will be responsible for managing all aspects of GreenLight's financial operations.
Prior to joining GreenLight, Keefe worked for 25 years in financial positions across the biotech, consumer packaged goods and health care industries. Most recently, she served as financial consultant to a range of life science companies with Danforth Advisors.
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees
GXO appointed to manage NHS England bowel cancer home testing kits